InsidersTradesSigma
Follow the 泽璟制药 stock price and the full management transaction log of the company, a listed equity based in China. Shares are quoted on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 泽璟制药 has published 32 reports. Market capitalisation: €29.4bn. The latest transaction was reported on 16 April 2026 (Sale). Among the most active insiders: ZELIN SHENG(盛泽林). The full history is free.
32
Insider Decl.
n/a
Thresholds
€2m
31 ops.
Buy Volume
€3m
1 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 15,642 of 28,832 companies
49.7
score / 100
Value33
Quality67
FCF yld-0.7%
Earn yld-0.5%
EV/EBITDA·
ROE38%
Gross mgn90%
Net mgn-20%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 16 April 2026
Declarations32 total
273,907 sharesA股XSHGSSE:273000000422970880
1,784 sharesA股XSHGSSE:173000005692962100
200 sharesA股XSHGSSE:173000005662820540
2,079 sharesA股XSHGSSE:173000005659772930
1,050 sharesA股XSHGSSE:173000005649137920
2,360 sharesA股XSHGSSE:173000005649150940
2,000 sharesA股XSHGSSE:173000005547914300
920 sharesA股XSHGSSE:173000005547914780
8,000 sharesA股XSHGSSE:173000005547913570
3,500 sharesA股XSHGSSE:173000005539713440
27,380 sharesA股XSHGSSE:173000005378757300
2,000 sharesA股XSHGSSE:173000005367543580
30,000 sharesA股XSHGSSE:173000005367546620
11,000 sharesA股XSHGSSE:173000005365277760
8,820 sharesA股XSHGSSE:173000005365279170
7,000 sharesA股XSHGSSE:173000005361184800
25 of 32 declarations
About 泽璟制药
Zai Lab is a company focused on developing innovative medicines, particularly in oncology. It is listed on the Shanghai Stock Exchange.